Mills C D, North R J, Dye E S
J Exp Med. 1981 Sep 1;154(3):621-30. doi: 10.1084/jem.154.3.621.
It was shown that subcutaneous implantation of P815 tumor cells admixed with Corynebacterium parvum resulted in the emergence of a tumor that grew for 9-10 d and then regressed. The onset of tumor aggression was preceded by the substantial generation in the draining lymph node and spleen of T cells capable of specifically lysing P815 target cells in vitro. The finding that the magnitude of this cytolytic response was much greater than the cytolytic response to a control tumor that grew progressively is consistent with the hypothesis that the anti-tumor action of C. parvum is based on its capacity to augment the production of T cells sensitized to tumor-specific transplantation antigens. This adjuvant action of C. parvum was revealed by additional experiments in which irradiated, nonreplicating tumor cells were substituted for living tumor cells in the admixture. The results support the conclusion that the potentiated cytolytic response to subcutaneous injection of an admixture of irradiated tumor cells and C. parvum is responsible for the ability of this admixture to cause the regression of a test tumor growing at a distant site. Finally, it was shown that the failure of the therapeutic admixture to cause the regression of distant test tumors above a certain size was associated with a failure of the admixture to cause a potentiated, anti-tumor cytolytic response. We discussed the possibility that this failure was caused by the presence of a tumor-induced state of immunosuppression.
研究表明,皮下植入与短小棒状杆菌混合的P815肿瘤细胞会产生一个肿瘤,该肿瘤生长9 - 10天然后消退。在肿瘤侵袭开始之前,引流淋巴结和脾脏中会大量产生能够在体外特异性裂解P815靶细胞的T细胞。与对逐渐生长的对照肿瘤的细胞溶解反应相比,这种细胞溶解反应的强度要大得多,这一发现与以下假设一致:短小棒状杆菌的抗肿瘤作用基于其增强对肿瘤特异性移植抗原致敏的T细胞产生的能力。短小棒状杆菌的这种佐剂作用在其他实验中得到了揭示,在这些实验中,用经辐射的、不复制的肿瘤细胞替代混合物中的活肿瘤细胞。结果支持了这样的结论:对皮下注射经辐射的肿瘤细胞和短小棒状杆菌混合物的增强的细胞溶解反应,是该混合物导致远处生长的测试肿瘤消退的原因。最后,研究表明,治疗性混合物不能使超过一定大小的远处测试肿瘤消退,这与混合物未能引起增强的抗肿瘤细胞溶解反应有关。我们讨论了这种失败可能是由肿瘤诱导的免疫抑制状态导致的可能性。